158 related articles for article (PubMed ID: 34728807)
1. Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer.
Arai H; Elliott A; Millstein J; Xiu J; Ou FS; Innocenti F; Wang J; Battaglin F; Jayachandran P; Kawanishi N; Soni S; Zhang W; Sohal D; Goldberg RM; Hall MJ; Scott AJ; Khushman M; Hwang JJ; Lou E; Weinberg BA; Lockhart AC; Shields AF; Abraham JP; Magee D; Stafford P; Zhang J; Venook AP; Korn WM; Lenz HJ
Oncogene; 2022 Jan; 41(2):260-267. PubMed ID: 34728807
[TBL] [Abstract][Full Text] [Related]
2. SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients.
Mei Z; Shao YW; Lin P; Cai X; Wang B; Ding Y; Ma X; Wu X; Xia Y; Zhu D; Shu Y; Fu Z; Gu Y
BMC Cancer; 2018 Apr; 18(1):479. PubMed ID: 29703253
[TBL] [Abstract][Full Text] [Related]
3. Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
Tak E; Kim M; Cho Y; Choi S; Kim J; Han B; Kim HD; Jang CS; Kim JE; Hong YS; Kim SY; Kim TW
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34779495
[TBL] [Abstract][Full Text] [Related]
4. Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations.
Kaplan HG; Rostad S; Ross JS; Ali SM; Millis SZ
J Natl Compr Canc Netw; 2018 Aug; 16(8):967-974. PubMed ID: 30099373
[No Abstract] [Full Text] [Related]
5. Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.
Führer S; Tollinger M; Dunzendorfer-Matt T
J Mol Biol; 2019 Sep; 431(19):3889-3899. PubMed ID: 31401120
[TBL] [Abstract][Full Text] [Related]
6. PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer.
Sood A; McClain D; Maitra R; Basu-Mallick A; Seetharam R; Kaubisch A; Rajdev L; Mariadason JM; Tanaka K; Goel S
Clin Colorectal Cancer; 2012 Jun; 11(2):143-50. PubMed ID: 22285706
[TBL] [Abstract][Full Text] [Related]
7. KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis.
Rabara D; Tran TH; Dharmaiah S; Stephens RM; McCormick F; Simanshu DK; Holderfield M
Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22122-22131. PubMed ID: 31611389
[No Abstract] [Full Text] [Related]
8. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.
Therkildsen C; Bergmann TK; Henrichsen-Schnack T; Ladelund S; Nilbert M
Acta Oncol; 2014 Jul; 53(7):852-64. PubMed ID: 24666267
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
10. NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas.
Tlemsani C; Pécuchet N; Gruber A; Laurendeau I; Danel C; Riquet M; Le Pimpec-Barthes F; Fabre E; Mansuet-Lupo A; Damotte D; Alifano M; Luscan A; Rousseau B; Vidaud D; Varin J; Parfait B; Bieche I; Leroy K; Laurent-Puig P; Terris B; Blons H; Vidaud M; Pasmant E
Cancer Med; 2019 Aug; 8(9):4330-4337. PubMed ID: 31199580
[TBL] [Abstract][Full Text] [Related]
11. NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma.
Mahalingam M
Adv Anat Pathol; 2017 Jan; 24(1):1-14. PubMed ID: 27941538
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients.
Nakayama I; Shinozaki E; Matsushima T; Wakatsuki T; Ogura M; Ichimura T; Ozaka M; Takahari D; Suenaga M; Chin K; Mizunuma N; Yamaguchi K
BMC Cancer; 2017 Jan; 17(1):38. PubMed ID: 28068936
[TBL] [Abstract][Full Text] [Related]
13. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors.
Ki DH; He S; Rodig S; Look AT
Oncogene; 2017 Feb; 36(8):1058-1068. PubMed ID: 27477693
[TBL] [Abstract][Full Text] [Related]
15.
Hayashi T; Desmeules P; Smith RS; Drilon A; Somwar R; Ladanyi M
Clin Cancer Res; 2018 Mar; 24(6):1436-1447. PubMed ID: 29127119
[No Abstract] [Full Text] [Related]
16. DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.
Wu S; Meng Q; Zhang C; Sun H; Lu R; Gao N; Yang H; Li X; Aschner M; Chen R
Int J Cancer; 2018 Jul; 143(2):289-297. PubMed ID: 29446085
[TBL] [Abstract][Full Text] [Related]
17. Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer.
Sokol ES; Feng YX; Jin DX; Basudan A; Lee AV; Atkinson JM; Chen J; Stephens PJ; Frampton GM; Gupta PB; Ross JS; Chung JH; Oesterreich S; Ali SM; Hartmaier RJ
Ann Oncol; 2019 Jan; 30(1):115-123. PubMed ID: 30423024
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenic alterations within the neurofibromin gene in various cancers].
Nagy Á; Garzuly F; Kálmán B
Magy Onkol; 2017 Dec; 61(4):327-336. PubMed ID: 29257151
[TBL] [Abstract][Full Text] [Related]
19. Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment.
Jour G; Illa-Bochaca I; Ibrahim M; Donnelly D; Zhu K; Miera EV; Vasudevaraja V; Mezzano V; Ramswami S; Yeh YH; Winskill C; Betensky RA; Mehnert J; Osman I
J Invest Dermatol; 2023 Mar; 143(3):444-455.e8. PubMed ID: 35988589
[TBL] [Abstract][Full Text] [Related]
20. Restoring functional neurofibromin by protein transduction.
Mellert K; Lechner S; Lüdeke M; Lamla M; Möller P; Kemkemer R; Scheffzek K; Kaufmann D
Sci Rep; 2018 Apr; 8(1):6171. PubMed ID: 29670214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
